Last reviewed · How we verify

NCT05548335

Measurement of the Optic Nerve Sheath Diameter

Status unknown NA Last updated 8 August 2023
What this trial tests

NA trial testing Ocular Ultrasound in Optic Nerve in 30 participants. Status unknown.

Timeline
1 October 2022
Primary endpoint
30 December 2024
31 December 2024

Quick facts

Lead sponsorCleveland Clinic Akron General
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment30
Start date1 October 2022
Primary completion30 December 2024
Estimated completion31 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cleveland Clinic Akron General

Who can join

18 and older, any sex, with Optic Nerve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective assessment of the accuracy of ocular ultrasound as a tool to measure the diameter of the optic nerve sheath and the eyeball transverse diameter in healthy adult patients presenting to the Emergency Department and have confirmatory imaging of the optic nerve as part of their clinical care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Optic Nerve

Currently open trials in the same condition.

Other Cleveland Clinic Akron General trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05548335.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing